05/17/2024
6:11 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:11 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:12 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:12 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:35 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:46 PM | Recursion Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024
5:24 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Bill Gates is all about this tiny $2 stock (Ad) What does Bill Gates know about this tiny company that we don’t?
From the outside, it looks like a worthless $2 stock… >>Click here to discover why Bill Gates is all about this tiny $2 stock. |
05/02/2024
4:41 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
9:43 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
11:49 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
3:19 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
5:41 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
4:16 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
4:29 PM | Recursion Pharmaceuticals (Filer)
| Form ARS | |
04/18/2024
4:12 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
4:12 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:18 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:55 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144/A | |
04/16/2024
3:15 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
7:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
4:44 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
10:13 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
9:39 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
4:42 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:42 PM | Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:43 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:43 PM | CHAVEZ R. MARTIN (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:43 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
10:09 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
4:01 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:40 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:43 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
5:39 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
4:38 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:35 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
3:35 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
6:28 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
3:32 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
6:08 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:53 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad) For over four decades, Louis Navellier has found the very best tech stocks...
Before the rest of the market. Click for his six specific AI stock in the crosshairs |
03/06/2024
4:39 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:59 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
7:25 AM | Recursion Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/23/2024
6:22 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
5:13 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
4:37 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
3:29 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
6:57 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
6:58 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
6:59 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:00 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:55 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:00 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:01 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:03 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
11:21 AM | ARK Investment Management LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
4:34 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
02/08/2024
5:54 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:40 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
5:52 PM | Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
01/25/2024
5:13 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
9:13 AM | Recursion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024
3:20 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
5:37 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:39 PM | Recursion Pharmaceuticals (Issuer)
Virani Shafique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:34 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:55 AM | Recursion Pharmaceuticals (Subject)
Virani Shafique (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
5:50 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:51 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
4:02 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:14 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:15 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
6:59 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
7:03 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:11 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:11 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:11 PM | CHAVEZ R. MARTIN (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:58 PM | Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:48 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:11 PM | Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:32 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
6:22 PM | Recursion Pharmaceuticals (Issuer)
Virani Shafique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:44 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:08 AM | Recursion Pharmaceuticals (Subject)
Virani Shafique (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
7:38 AM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
12/15/2023
7:41 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad) For over four decades, Louis Navellier has found the very best tech stocks...
Before the rest of the market. Click for his six specific AI stock in the crosshairs |
12/14/2023
5:51 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
5:53 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
12:58 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
10:15 AM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
3:24 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
9:46 AM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
4:22 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
1:57 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/30/2023
4:41 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
